Vineet Laboratories (NSE:VINEETLAB) Beta: 1.5390 (As of Jul. 04, 2026)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
41 GF Score
Price ₹33.65
GF Value ₹15.35
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories Beta?

Vineet Laboratories NSE:VINEETLAB +0.09% 41 Beta is 1.5390 as of Jul. 04, 2026. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 41/100 and a GF Value™ of ₹15.35 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-04), Vineet Laboratories's Beta is 1.5390.


Vineet Laboratories  (NSE:VINEETLAB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Vineet Laboratories Beta Related Terms


Vineet Laboratories Beta Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories Beta Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 1.02

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 1.02 1.34 1.37 1.85

NSE:VINEETLAB vs DOW: Beta Comparison

For the Chemicals subindustry, Vineet Laboratories's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories Beta vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Beta distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's Beta falls into.


NSE:VINEETLAB
41GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5390 mean?
Vineet Laboratories (NSE:VINEETLAB) has a Beta of 1.5390 as of Jul. 04, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vineet Laboratories and its competitors.
Is Vineet Laboratories' Beta too high?
Vineet Laboratories' current Beta is 1.5390. Overall, Vineet Laboratories has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Beta compare to DOW?
Vineet Laboratories' Beta of 1.5390 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vineet Laboratories and its competitors. Vineet Laboratories's current Beta is 1.5390. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.35, compared to a current price of ₹33.65 — trading 119.2% above its estimated fair value. The current Beta is 1.5390. Vineet Laboratories' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Beta is 1.5390 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹33.65 is trading 119.2% above its estimated GF Value™ of ₹15.35. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Beta: 1.5390
  • GF Value™: ₹15.35 vs. price of ₹33.65 (119.2% above fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
41GF Score

Get the complete analysis for NSE:VINEETLAB

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.65
Price
₹15.35
GF Value